ACAline Millani Carneiro

Aline Millani Carneiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aline Millani Carneiro has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Avaliação de Prejuízo Cognitivo em Sobreviventes de Câncer de Mama: Estudo Transversal

    by Renata Nunes Pedras, Maria Fernanda Marcusso Manhães, Aline Millani Carneiro, Getulio Yuzo Okuma, Simone Elias, Edvane Birelo Lopes De Domenico, Cristiane Decat Bergerot

    Resumo Estudo prospectivo e transversal, para determinar a prevalência de prejuízo cognitivo decorrente da quimioterapia e explorar fatores preditores e mediadores em sobreviventes de câncer de mama. Utilizou-se o Termômetro de Distress, Escala de Ansiedade e Depressão, Functional Assessment of Chronic Illness Therapy-General e Cognitive Function. As sobreviventes (N = 62) reportaram uma alta prevalência de distress (46,8%) e de ansiedade (24,2%), com baixos escores nas subescalas déficit cognitivo e habilidades cognitivas percebidos. O funcionamento cognitivo esteve associado à idade (β = 1,42; p = 0,002), atuação profissional (β = -23,12; p = 0,004), depressão (β = -5,43; p = 0,001) e qualidade de vida (β = 1,24; p = 0,001). Prejuízo cognitivo deve ser considerado no serviço de Psico-Oncologia.


  • Metabolic Profile in Patients with Mild Obstructive Sleep Apnea

    by Luciana Oliveira e Silva, Thais M. Guimarães, Gabriela P. Luz, Glaury Coelho, Luciana Badke, Ildonete R. Almeida, Aline Millani-Carneiro, Sergio Tufik, Lia Bittencourt, Sonia M. Togeiro

    Background: Mild obstructive sleep apnea (OSA) is a highly prevalent disorder in adults. However, it is not clear whether mild OSA has significant metabolic complications. This study examined the prevalence of metabolic syndrome (MS) in patients with mild OSA compared to control group. Methods: Adults (18–65 years of age) of both genders with a body mass index (BMI) ≤35 kg/m2 were included. The mild OSA group comprised of patients with an apnea–hypopnea index (AHI) score of ≥5 but ≤15 events/hr of sleep, independent of other symptoms. The control group (CG) comprised individuals with an AHI of Results: Thirty-two percent of mild OSA patients had MS, 43.5% of mild OSA patients had hypertension, 14% showed dyslipidemia, and 56% had prediabetes. The OSA group showed increased TG (CG: 90.0 ± 51.9 vs. OSA: 140.3 ± 78.2 mg/dL, P = 0.004), and TG/HDL-c (CG: 1.9 ± 1.4 vs. OSA: 3.1 ± 2.0, P = 0.05), independent of adjustments. Independent of obesity (BMI 2), there was a negative correlation between total cholesterol and TG with mean oxygen saturation, independent of obesity (BMI 2). Conclusions: Our findings showed dysregulation in lipid profiles after adjustments for confounders in the mild OSA group, and there was a correlation between these parameters and sleep hypoxemia. The TG/HDL-c ratio in particular was high, suggesting that it might be investigated as a marker of a detrimental metabolic profile in these patients.


  • Impaired sustained attention and lapses are present in patients with mild obstructive sleep apnea

    by Gabriela Pontes Luz, Thais Moura Guimarães, Terri E. Weaver, Luiz E. Nery, Luciana Oliveira e Silva, Luciana Badke, Glaury Coelho, Aline Millani-Carneiro, Sergio Tufik, Lia Bittencourt

    Background Severe obstructive sleep apnea (OSA) directly affects the quality of life, mood, and sustained attention of individuals, but it has not yet been established in the literature, if these changes also affect patients with mild OSA. The purpose of this study was to investigate such negative effects on the parameters described above. Methods A controlled study was held at the Universidade Federal de Sao Paulo, Department of Psychobiology. Thirty-nine mild OSA patients and 25 controls were included. Volunteers could be of both genders with body mass index (BMI) ≤35 kg/m2 and age between 18 and 65 years. Both groups were subjected to full-night polysomnography (PSG), the subjective assessment of mood (Beck Inventory of Anxiety and Depression), Functional Outcomes of Sleep Questionnaire (FOSQ), and the psychomotor vigilance task (PVT) five times during the day. We considered mild OSA patients those with apnea–hypopnea index (AHI) score between 5 and 15. The control group included subjects with AHI scores p = 0.004). Conclusions Patients with mild OSA showed increased sustained attention lapses compared with normal subjects.


  • Short sleep duration and obesity: mechanisms and future perspectives

    by Ioná Zalcman Zimberg, Ana Dâmaso, Mariana Del Re, Aline Millani Carneiro, Helton de Sá Souza, Fábio Santos de Lira, Sergio Tufik, Marco Túlio de Mello

    A reduction of sleep time has become common over the last century, and growing evidence from both epidemiological and laboratory‐based studies suggests sleep curtailment is a new risk factor for the development of obesity. On this basis, the present review examines the role of sleep curtailment in the metabolic and endocrine alterations, including decreased glucose tolerance and insulin sensitivity, increased evening concentrations of cortisol, increased levels of ghrelin, decreased levels of leptin and increased hunger and appetite. It will be discussed how sleep restriction may lead to increase in food intake and result in greater fatigue, which may favour decreased energy expenditure. Altogether, evidences point to a possible role of decreased sleep duration in the current epidemic of obesity and therefore present literature highlights the importance of getting enough good sleep for metabolic health. Many aspects still need to be clarified and intervention studies also need to be conducted. Copyright © 2012 John Wiley & Sons, Ltd.